摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2, 6-dichloro-7-(2, 2, 2-trifluoroethyl)-7H-purine | 1227047-31-5

中文名称
——
中文别名
——
英文名称
2, 6-dichloro-7-(2, 2, 2-trifluoroethyl)-7H-purine
英文别名
2,6-Dichloro-7-(2,2,2-trifluoroethyl)-7H-purine;2,6-dichloro-7-(2,2,2-trifluoroethyl)purine
2, 6-dichloro-7-(2, 2, 2-trifluoroethyl)-7H-purine化学式
CAS
1227047-31-5
化学式
C7H3Cl2F3N4
mdl
——
分子量
271.029
InChiKey
QXLVAISNZXCKGB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    266.0±50.0 °C(Predicted)
  • 密度:
    1.85±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    43.6
  • 氢给体数:
    0
  • 氢受体数:
    6

安全信息

  • 危险性防范说明:
    P261,P280,P301+P312,P302+P352,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2, 6-dichloro-7-(2, 2, 2-trifluoroethyl)-7H-purine5-(1,1-二甲基乙基)-2-甲基苯胺N,N-二异丙基乙胺 作用下, 以 乙醇 为溶剂, 生成 N-(5-(tert-butyl)-2-methylphenyl)-2-chloro-7-(2,2,2-trifluoroethyl)-7H-purin-6-amine
    参考文献:
    名称:
    Purine derivatives as potent γ-secretase modulators
    摘要:
    The development of a novel series of purines as gamma-secretase modulators for potential use in the treatment of Alzheimer's disease is disclosed herein. Optimization of a previously disclosed pyrimidine series afforded a series of potent purine-based gamma-secretase modulators with 300- to 2000-fold in vitro selectivity over inhibition of Notch cleavage and that selectively reduces A beta 42 in an APP-YAC transgenic mouse model. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.02.008
  • 作为产物:
    描述:
    trifluoromethyl 2,2,2-trifluoroethylsulfonate2,6-二氯嘌呤甲基氯化镁 作用下, 以 四氢呋喃 为溶剂, 反应 16.5h, 以74%的产率得到2, 6-dichloro-7-(2, 2, 2-trifluoroethyl)-7H-purine
    参考文献:
    名称:
    Direct, Regioselective N-Alkylation of 1,3-Azoles
    摘要:
    Regioselective N-alkylation of 1,3-azoles is a valuable transformation. Organomagnesium reagents were discovered to be competent bases to affect regioselective alkylation of various 1,3-azoles. Counterintuitively, substitution selectively occurred at the more sterically hindered nitrogen atom. Numerous examples are provided, on varying 1,3-azole scaffolds, with yields ranging from 25 to 95%.
    DOI:
    10.1021/acs.orglett.5b02994
点击查看最新优质反应信息

文献信息

  • Direct, Regioselective <i>N</i>-Alkylation of 1,3-Azoles
    作者:Shuai Chen、Russell F. Graceffa、Alessandro A. Boezio
    DOI:10.1021/acs.orglett.5b02994
    日期:2016.1.4
    Regioselective N-alkylation of 1,3-azoles is a valuable transformation. Organomagnesium reagents were discovered to be competent bases to affect regioselective alkylation of various 1,3-azoles. Counterintuitively, substitution selectively occurred at the more sterically hindered nitrogen atom. Numerous examples are provided, on varying 1,3-azole scaffolds, with yields ranging from 25 to 95%.
  • Purine derivatives as potent γ-secretase modulators
    作者:Alexey Rivkin、Sean P. Ahearn、Stephanie M. Chichetti、Christopher L. Hamblett、Yudith Garcia、Michelle Martinez、Jed L. Hubbs、Michael H. Reutershan、Matthew H. Daniels、Phieng Siliphaivanh、Karin M. Otte、Chaomin Li、Andrew Rosenau、Laura M. Surdi、Joon Jung、Bethany L. Hughes、Jamie L. Crispino、George N. Nikov、Richard E. Middleton、Christopher M. Moxham、Alexander A. Szewczak、Sanjiv Shah、Lily Y. Moy、Candia M. Kenific、Flobert Tanga、Jonathan C. Cruz、Paula Andrade、Minilik H. Angagaw、Nirah H. Shomer、Thomas Miller、Benito Munoz、Mark S. Shearman
    DOI:10.1016/j.bmcl.2010.02.008
    日期:2010.4
    The development of a novel series of purines as gamma-secretase modulators for potential use in the treatment of Alzheimer's disease is disclosed herein. Optimization of a previously disclosed pyrimidine series afforded a series of potent purine-based gamma-secretase modulators with 300- to 2000-fold in vitro selectivity over inhibition of Notch cleavage and that selectively reduces A beta 42 in an APP-YAC transgenic mouse model. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多